{"id":"https://openalex.org/W7148961834","doi":"https://doi.org/10.1158/1538-7445.am2026-6637","title":"Abstract 6637: Real world outcomes for patients with KRAS G12D -mutated non-small cell lung cancer: A University of California Health Data Warehouse retrospective analysis.","display_name":"Abstract 6637: Real world outcomes for patients with KRAS G12D -mutated non-small cell lung cancer: A University of California Health Data Warehouse retrospective analysis.","publication_year":2026,"publication_date":"2026-04-03","ids":{"openalex":"https://openalex.org/W7148961834","doi":"https://doi.org/10.1158/1538-7445.am2026-6637"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2026-6637","doi":"https://doi.org/10.1158/1538-7445.am2026-6637","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-6637","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5126338990","display_name":"Jingtong Liang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingtong Liang","raw_affiliation_strings":["1University of California Los Angeles - UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California Los Angeles - UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039420902","display_name":"Tali Azenkot","orcid":"https://orcid.org/0000-0003-3329-6381","observed_orcids":["https://orcid.org/0000-0003-3329-6381"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tali Azenkot","raw_affiliation_strings":["2University of California San Diego - Moores Cancer Center, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of California San Diego - Moores Cancer Center, San Diego, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109732497","display_name":"S. Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandip Patel","raw_affiliation_strings":["2University of California San Diego - Moores Cancer Center, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of California San Diego - Moores Cancer Center, San Diego, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"86","issue":"7_Supplement","first_page":"6637","last_page":"6637"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-g12d-mutation","display_name":"KRAS G12D mutation","score":0.9089999794960022},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9679999947547913},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8939999938011169},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9869999885559082},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.8669999837875366},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9810000061988831},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/time-on-treatment","display_name":"time on treatment","score":0.8289999961853027},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8790000081062317},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.7570000290870667},{"id":"https://openalex.org/keywords/kras-g12c","display_name":"KRAS G12C","score":0.7450000047683716},{"id":"https://openalex.org/keywords/never-smokers","display_name":"never smokers","score":0.6959999799728394},{"id":"https://openalex.org/keywords/hispanic-patients","display_name":"Hispanic patients","score":0.6930000185966492},{"id":"https://openalex.org/keywords/racial-and-ethnic-disparities","display_name":"racial and ethnic disparities","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.921999990940094},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9053999781608582},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6331999897956848},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.603600025177002},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5843999981880188},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5756000280380249},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5152000188827515},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.49230000376701355},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43149998784065247},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.41659998893737793},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.3758000135421753},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.3425000011920929},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.3111000061035156},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.3012000024318695},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.2865000069141388},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.27469998598098755},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.25859999656677246},{"id":"https://openalex.org/C169382597","wikidata":"https://www.wikidata.org/wiki/Q21208025","display_name":"Programmed cell death 1","level":5,"score":0.25060001015663147}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2026-6637","doi":"https://doi.org/10.1158/1538-7445.am2026-6637","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-6637","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4407392022","https://openalex.org/W7201847533","https://openalex.org/W4414556611","https://openalex.org/W4308974749","https://openalex.org/W3127560436","https://openalex.org/W7133531998","https://openalex.org/W4403093468","https://openalex.org/W7208779682","https://openalex.org/W4362541218","https://openalex.org/W3129670908"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"KRAS":[2,27,48,51,79,142,149,198,206,228,266,285,302],"is":[3,68],"the":[4,82,106,109,270,321],"most":[5,21],"common":[6],"driver":[7],"mutation":[8],"in":[9,81,222],"non-small":[10,304],"cell":[11,305],"lung":[12,306],"cancer":[13],"(NSCLC),":[14],"with":[15,26,36,47,64,76,141,147,177,180,184,188,196,205,227,264,284,301],"G12C":[16],"and":[17,77,98,126,144,162,186,220,246],"G12D":[18,28,207,229],"among":[19],"its":[20],"frequent":[22],"point":[23],"mutations.":[24,150,267],"Patients":[25,151],"mutations":[29,80],"are":[30,54],"more":[31,202],"likely":[32],"to":[33,39,45,117,194],"be":[34],"never-smokers":[35],"worse":[37],"response":[38],"immune":[40],"checkpoint":[41],"inhibitors":[42],"(ICI)":[43],"compared":[44],"those":[46,263],"G12C.":[49],"As":[50],"G12D-targeted":[52],"therapies":[53],"under":[55],"development,":[56],"a":[57,153,223,273],"greater":[58],"understanding":[59],"of":[60,84,93,157,233,272,310,320],"real-world":[61,280],"outcomes":[62,281,298],"associated":[63],"current":[65],"standard-of-care":[66],"treatments":[67],"warranted.":[69],"Methods:":[70],"We":[71,132],"retrospectively":[72],"analyzed":[73],"NSCLC":[74,135],"patients":[75,139,195,204,226,283,300],"without":[78],"University":[83,309],"California":[85,311],"Health":[86,312],"Data":[87,313],"Warehouse.":[88],"Time":[89],"on":[90],"treatment":[91],"(ToT)":[92],"first-line":[94],"ICIs":[95,234],"was":[96,103],"estimated,":[97],"ICI-related":[99,247],"overall":[100],"survival":[101],"(OS)":[102],"defined":[104],"as":[105,262],"time":[107],"from":[108,282],"first":[110],"ICI":[111],"infusion":[112],"until":[113],"death":[114],"or":[115,191],"loss":[116],"follow":[118],"up.":[119],"Kaplan-Meier":[120],"analysis,":[121],"Cox":[122,224],"proportional":[123],"hazards":[124],"model,":[125,225],"student\u2019s":[127],"t-test":[128],"were":[129,164,175,201],"applied.":[130],"Results:":[131],"identified":[133],"3,391":[134],"patients,":[136,211],"including":[137],"158":[138],"(5%)":[140],"G12D,":[143],"735":[145],"(22%)":[146],"other":[148,197,265],"had":[152,230],"median":[154],"(range)":[155],"age":[156],"64":[158],"(20-89)":[159],"upon":[160],"diagnosis":[161],"57%":[163],"female":[165],"(Table).":[166],"Among":[167],"842":[168],"patient":[169],"(25%)":[170],"who":[171],"received":[172],"ICIs,":[173],"58%":[174],"treated":[176],"pembrolizumab,":[178],"20%":[179],"nivolumab":[181],"(including":[182],"5%":[183],"ipilimumab),":[185],"8%":[187],"either":[189],"atezolizumab":[190],"durvalumab.":[192],"Compared":[193],"mutations,":[199],"there":[200],"Hispanic":[203],"(20":[208],"versus":[209,236,250],"36":[210],"p":[212,239,253],"<":[213],"0.01).":[214],"When":[215],"adjusting":[216],"for":[217,299,324],"age,":[218],"race,":[219],"ethnicity":[221],"similar":[231],"ToT":[232],"(4.3":[235],"4.8":[237],"months;":[238,252],"=":[240,254],"0.25;":[241],"HR,":[242,256],"95%CI:":[243,257],"1.30,":[244],"0.83-2.04)":[245],"OS":[248],"(9.4":[249],"14.0":[251],"0.36;":[255],"1.23,":[258],"0.79":[259],"-":[260],"1.92)":[261],"Conclusion:":[268],"Harnessing":[269],"power":[271],"structured,":[274],"multicenter":[275],"data":[276],"collective,":[277],"we":[278],"describe":[279],"G12D-mutated":[286,303],"NSCLC.":[287],"Citation":[288],"Format:":[289],"Jingtong":[290],"Liang,":[291],"Tali":[292],"Azenkot,":[293],"Sandip":[294],"Patel.":[295],"Real":[296],"world":[297],"cancer:":[307],"A":[308],"Warehouse":[314],"retrospective":[315],"analysis":[316],"[abstract].":[317],"In:":[318],"Proceedings":[319],"American":[322],"Association":[323],"Cancer":[325,343],"Research":[326],"Annual":[327],"Meeting":[328],"2026;":[329],"Part":[330],"1":[331],"(Regular":[332],"Abstracts);":[333],"2026":[334],"Apr":[335],"17-22;":[336],"San":[337],"Diego,":[338],"CA.":[339],"Philadelphia":[340],"(PA):":[341],"AACR;":[342],"Res":[344],"2026;86(7":[345],"Suppl):Abstract":[346],"nr":[347],"6637.":[348]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2026-04-04T00:00:00"}